Literature DB >> 19863559

Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes.

Frederic Dalle1, Betty Wächtler, Coralie L'Ollivier, Gudrun Holland, Norbert Bannert, Duncan Wilson, Catherine Labruère, Alain Bonnin, Bernhard Hube.   

Abstract

The human pathogenic fungus Candida albicans can cause systemic infections by invading epithelial barriers to gain access to the bloodstream. One of the main reservoirs of C. albicans is the gastrointestinal tract and systemic infections predominantly originate from this niche. In this study, we used scanning electron and fluorescence microscopy, adhesion, invasion and damage assays, fungal mutants and a set of fungal and host cell inhibitors to investigate the interactions of C. albicans with oral epithelial cells and enterocytes. Our data demonstrate that adhesion, invasion and damage by C. albicans depend not only on fungal morphology and activity, but also on the epithelial cell type and the differentiation stage of the epithelial cells, indicating that epithelial cells differ in their susceptibility to the fungus. C. albicans can invade epithelial cells by induced endocytosis and/or active penetration. However, depending on the host cell faced by the fungus, these routes are exploited to a different extent. While invasion into oral cells occurs via both routes, invasion into intestinal cells occurs only via active penetration.

Entities:  

Mesh:

Year:  2009        PMID: 19863559     DOI: 10.1111/j.1462-5822.2009.01394.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  131 in total

1.  Candida species differ in their interactions with immature human gastrointestinal epithelial cells.

Authors:  Christina Falgier; Sara Kegley; Heather Podgorski; Timothy Heisel; Kathleen Storey; Catherine M Bendel; Cheryl A Gale
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 2.  Hyphal development in Candida albicans from different cell states.

Authors:  Chang Su; Jing Yu; Yang Lu
Journal:  Curr Genet       Date:  2018-05-23       Impact factor: 3.886

3.  The NDR Kinase Cbk1 Downregulates the Transcriptional Repressor Nrg1 through the mRNA-Binding Protein Ssd1 in Candida albicans.

Authors:  Hye-Jeong Lee; Jong-Myeong Kim; Woo Kyu Kang; Heebum Yang; Jeong-Yoon Kim
Journal:  Eukaryot Cell       Date:  2015-05-22

Review 4.  Growth of Candida albicans hyphae.

Authors:  Peter E Sudbery
Journal:  Nat Rev Microbiol       Date:  2011-08-16       Impact factor: 60.633

Review 5.  Candida albicans hyphal initiation and elongation.

Authors:  Yang Lu; Chang Su; Haoping Liu
Journal:  Trends Microbiol       Date:  2014-09-25       Impact factor: 17.079

6.  Comparative Analysis of Transmembrane Regulators of the Filamentous Growth Mitogen-Activated Protein Kinase Pathway Uncovers Functional and Regulatory Differences.

Authors:  Hema Adhikari; Lauren M Caccamise; Tanaya Pande; Paul J Cullen
Journal:  Eukaryot Cell       Date:  2015-06-26

Review 7.  Host cell invasion by medically important fungi.

Authors:  Donald C Sheppard; Scott G Filler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

8.  Yeast and Filaments Have Specialized, Independent Activities in a Zebrafish Model of Candida albicans Infection.

Authors:  Brittany G Seman; Jessica L Moore; Allison K Scherer; Bailey A Blair; Sony Manandhar; Joshua M Jones; Robert T Wheeler
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

9.  Streptococcus oralis and Candida albicans Synergistically Activate μ-Calpain to Degrade E-cadherin From Oral Epithelial Junctions.

Authors:  Hongbin Xu; Takanori Sobue; Martinna Bertolini; Angela Thompson; Anna Dongari-Bagtzoglou
Journal:  J Infect Dis       Date:  2016-05-13       Impact factor: 5.226

10.  Host cell invasion and virulence mediated by Candida albicans Ssa1.

Authors:  Jianing N Sun; Norma V Solis; Quynh T Phan; Jashanjot S Bajwa; Helena Kashleva; Angela Thompson; Yaoping Liu; Anna Dongari-Bagtzoglou; Mira Edgerton; Scott G Filler
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.